Your search returned 4 results.

Results
	1.	Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors: Swain, Sandra M PMID: 26272770 Year: 2015 Citation: Lancet Oncology. 16(9):1037-48, 2015 Sep. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA DOI: http://dx.doi.org/10.1016/S1470-2045(15)00041-8 Add to cart (remove)
	2.	Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades. MedStar authors: Ihemelandu, Chukwuemeka Sugarbaker, Paul H PMID: 27878480 Year: 2017 Citation: Annals of Surgical Oncology. 24(4):898-905, 2017 Apr Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Surgery/General Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Ihemelandu C, Sugarbaker PH DOI: https://dx.doi.org/10.1245/s10434-016-5698-x Add to cart (remove)
	3.	Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. [Review] MedStar authors: Sugarbaker, Paul H PMID: 33004272 Year: 2021 Citation: European Journal of Surgical Oncology. 47(4):738-742, 2021 Apr. Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Evans S, Nagourney AJ, Nagourney RA, Sugarbaker PH, Tran PH DOI: https://dx.doi.org/10.1016/j.ejso.2020.09.017 Add to cart (remove)
	4.	IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer. MedStar authors: Swain, Sandra M MedStar Health PMID: 38755096 Year: 2024 Citation: Annals of Oncology. 35(7):630-642, 2024 Jul. Department: Associate Dean for Research Development Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Dent R, Andre F, Goncalves A, Martin M, Schmid P, Schutz F, Kummel S, Swain SM, Bilici A, Loirat D, Villalobos Valencia R, Im SA, Park YH, De Laurentis M, Colleoni M, Guarneri V, Bianchini G, Li H, Kirchmayer Machackova Z, Mouta J, Deurloo R, Gan X, Fan M, Mani A, Swat A, Cortes J DOI: https://dx.doi.org/10.1016/j.annonc.2024.04.001 Add to cart (remove)

Powered by Koha